Mississippi Active Pharmaceutical Ingredient Quality Assurance Act regulates the sale and distribution of compounded drugs.
The Mississippi Active Pharmaceutical Ingredient Quality Assurance Act establishes requirements for the sale and distribution of compounded drugs. It prohibits the sale, transfer, or distribution of compounded drugs unless the compounder meets specific criteria, including using pharmaceutical-grade bulk drug substances and complying with federal regulations. The Board of Pharmacy is authorized to inspect entities involved in compounding drugs and to impose penalties for violations, including fines and license revocation.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.